Andreia D. Magalhaes

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Speech Biomarkers for Quantifying Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease.

Speech Biomarkers for Quantifying Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease.

Journal: Annals of neurology
Published: January 27, 2026

Low-frequency activity in the subthalamic nucleus informs about the acute neuropsychiatric state in Parkinson's disease.

Low-frequency activity in the subthalamic nucleus informs about the acute neuropsychiatric state in Parkinson's disease.

Journal: NPJ Parkinson's disease
Published: September 30, 2025

Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity.

Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity.

Journal: PLoS biology
Published: September 23, 2025

Digital speech biomarkers can measure acute effects of levodopa in Parkinson's disease.

Digital speech biomarkers can measure acute effects of levodopa in Parkinson's disease.

Journal: NPJ Parkinson's disease
Published: May 15, 2025

Detecting neuropsychiatric fluctuations in Parkinson's Disease using patients' own words: the potential of large language models.

Detecting neuropsychiatric fluctuations in Parkinson's Disease using patients' own words: the potential of large language models.

Journal: NPJ Parkinson's disease
Published: December 16, 2024

Finely Tuned γ Tracks Medication Cycles in Parkinson's Disease: An Ambulatory Brain-Sense Study.

Finely Tuned γ Tracks Medication Cycles in Parkinson's Disease: An Ambulatory Brain-Sense Study.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 04, 2024

Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease.

Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: November 27, 2024

Changes in sensor recorded activity patterns and neuropsychiatric symptoms after deep brain stimulation for Parkinson's disease: 5 case reports.

Changes in sensor recorded activity patterns and neuropsychiatric symptoms after deep brain stimulation for Parkinson's disease: 5 case reports.

Journal: BMC neurology
Published: August 05, 2024

Impulse Control Disorders and Effort-Based Decision-Making in Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.

Impulse Control Disorders and Effort-Based Decision-Making in Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.

Journal: Movement disorders clinical practice
Published: July 22, 2024

Neurophysiological gradient in the Parkinsonian subthalamic nucleus as a marker for motor symptoms and apathy.

Neurophysiological gradient in the Parkinsonian subthalamic nucleus as a marker for motor symptoms and apathy.

Journal: NPJ Parkinson's disease
Published: June 02, 2024

Subthalamic stimulation has acute psychotropic effects and improves neuropsychiatric fluctuations in Parkinson's disease.

Subthalamic stimulation has acute psychotropic effects and improves neuropsychiatric fluctuations in Parkinson's disease.

Journal: BMJ neurology open
Published: October 24, 2023

An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein.

An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein.

Journal: Cell reports
Published: December 21, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026